Chemoinformaics analysis of 3-O-(Alpha-L-Arabinopyranosyl-Beta-D-Glucopyranosyl)-Oleanolic
| Molecular Weight | 792.02 | nRot | 7 |
| Heavy Atom Molecular Weight | 722.468 | nRig | 40 |
| Exact Molecular Weight | 791.482 | nRing | 7 |
| Solubility: LogS | -3.396 | nHRing | 2 |
| Solubility: LogP | 3.435 | No. of Aliphatic Rings | 7 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 125 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 56 | No. of Aromatic Carbocycles | 0 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 69 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 43 | No. of Saturated Rings | 6 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 0 |
| nHA | 11 | APOL | 128.543 |
| nHD | 7 | BPOL | 78.4713 |
| QED | 0.146 |
| Synth | 5.775 |
| Natural Product Likeliness | 2.683 |
| NR-PPAR-gamma | 0.893 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.071 |
| Pgp-sub | 0.001 |
| HIA | 0.874 |
| CACO-2 | -5.462 |
| MDCK | 0.0000247 |
| BBB | 0.042 |
| PPB | 0.903527 |
| VDSS | 0.637 |
| FU | 0.0959133 |
| CYP1A2-inh | 0 |
| CYP1A2-sub | 0.13 |
| CYP2c19-inh | 0.002 |
| CYP2c19-sub | 0.381 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.085 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.11 |
| CYP3a4-inh | 0.061 |
| CYP3a4-sub | 0.076 |
| CL | 1.191 |
| T12 | 0.022 |
| hERG | 0.003 |
| Ames | 0.101 |
| ROA | 0.198 |
| SkinSen | 0.002 |
| Carcinogencity | 0.021 |
| EI | 0.002 |
| Respiratory | 0.382 |
| NR-Aromatase | 0.864 |
| Antiviral | Yes |
| Prediction | 0.852545 |